A pregnant woman took a routine prenatal test at 35, which gave her confusing results. Ultimately, it was the first sign of ...

Genfit has announced encouraging preliminary results from its phase 1b clinical trial evaluating investigational drug GNS561 in combination with a MEK inhibitor (MEKi) in patients with KRAS mutated ...

Highly encouraging early data from the ongoing Phase 1b study evaluating investigational drug GNS561 with a MEK inhibitor (MEKi) in KRAS mutated ...

When Cindy Mrotek and Katie Glenn became caregivers for their parents with cholangiocarcinoma, but they didn’t just find ...

Curtis Jackson was feeling fit and healthy in late 2020 when he decided to update his life insurance policy: He was in better shape than he'd been in a while, but he wanted to make sure his wife and ...

NANJING, China and GAITHERSBURG, Md., Dec. 4, 2025 /PRNewswire/ -- TransThera Sciences Inc. ("TransThera") announced the publication of clinical results from a US-based Phase 2 trial evaluating ...

Stacie C. Lindsey is being recognized for her patient advocacy, alignment of research efforts and collaboration among the cancer community. AstraZeneca and Scientific American Custom Media sponsor the ...

Lytgobi (futibatinib) marks the first medicine launched by Taiho Oncology Europe in the UK (2) For United Kingdom (UK) Trade and Medical Media Only ...